Abstract:To the Editor: We read with great interest the article by Grant and Olsen on the role of physicians and veterinarians in preventing zoonotic diseases in immunocompromised persons (1) and the letter by Barton et al. on the risk of pregnant women and young infants for petassociated illnesses (2). Essentially all aspects and conclusions of the study by Grant and Olsen are also valid in Europe. In Austria, veterinarians are well educated in zoonotic infections. However, it is impossible for practitioners to know all zoonotic agents in detail. In addition to immunocompromised persons, pregnant women, and young infants, persons in certain occupations are at higher risk for zoonotic infections. Veterinarians are one of these groups. We have completed seroepidemiologic studies involving veterinarians (3) and are testing other groups at high risk, such as slaughterhouse workers, farmers, and zoo employees. We surveyed 52% of the veterinarians in an Austrian federal state who agreed to participate in the study. They completed a questionnaire and provided case histories so that risk factors could be assessed. We also obtained blood samples. The sera were tested for antibodies to viral, bacterial, and parasitic zoonotic agents. After correlating the serologic results with the statements in the questionnaire, a statistical analysis, and another questionnaire of selected participants, we found transmission of zoonotic agents from animals to veterinarians for influenza A virus H1N1 (prevalence of the infection was much higher among veterinarians than in the general population; a significant number of seropositive veterinarians were swine practitioners [chisquare = pxx < .01]); Coxiella burnetii (veterinarians who removed bovine placenta without gloves had a higher risk [chi-square = pxxx < .001] of acquiring Coxiella burnetii infections); Brucella sp.; Chlamydia psittaci; Leptospira sp.; Toxoplasma gondii; and Toxocara canis/cati (antibody prevalence was 20 times higher among veterinarians than in the general Austrian population). As a result of the survey, veterinarians know about their professionspecific risk factors and take adequate measures to prevent infections; also, they are more qualified to advise pet owners and persons of other professions at high risk. In addition to the pathogens listed by Grant and Olsen and the agents listed in this letter, some other zoonotic agents present (at least in Central Europe) are cowpox (mainly acquired from cats; 4-6) and parapox viruses, lymphocytic choriomeningitis virus, Newcastle disease virus, Erysipelothrix rhusiopathiae, and Capillaria hepatica (7). On the other hand, animals are not the source of human disease such as leukemia; there is no evidence that feline leukemia virus and feline immunodeficiency virus, for example, are transmitted to humans (8). The risk of acquiring a zoonotic infection from a pet animal is definitely lower than the emotional and health benefits of pet ownership.

Genome-wide association study shows BCL 11 A associated with persistent fetal hemoglobin and amelioration of the phenotype of-thalassemia

A Genetic Variant Ameliorates Β-Thalassemia Severity by Epigenetic-Mediated Elevation of Human Fetal Hemoglobin Expression

Fetal Hemoglobin Regulation in Beta-Thalassemia

Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin

Genome-wide analysis of aberrantly expressed lncRNAs and miRNAs with associated co-expression and ceRNA networks in β-thalassemia and hereditary persistence of fetal hemoglobin

Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study

Plasma proteome profiling combined with clinical and genetic features reveals the pathophysiological characteristics of β-thalassemia

A natural DNMT1 mutation elevates the fetal hemoglobin level via epigenetic derepression of the γ-globin gene in β-thalassemia

[Advance of research on the role of BCL11A in the occurrence and treatment of β-Thalassemia]

The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria

Genetic modifications of EGLN1 reactivate HbF production in β0-thalassemia/HbE

Genome-wide methylation and gene-expression analyses in thalassemia

An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level

Preventing zoonotic diseases in immunocompromised persons: the role of physicians and veterinarians.

A novel 15.8 kb deletion α-thalassemia confirmed by long-read single-molecule real-time sequencing: Hematological phenotypes and molecular characterization

Human m6A-mRNA and lncRNA epitranscriptomic microarray reveal function of RNA methylation in hemoglobin H-constant spring disease

A 6-Year Follow-up of a Chinese Child with Homozygous β0-Thalaasemia and a Heterozygous KLF1 Mutation

Upregulation of miR‐6747‐3p affects red blood cell lineage development and induces fetal hemoglobin expression by targeting BCL11A in β‐thalassemia

BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations

Molecular characterization of similar Hb Lepore Boston-Washington in four Chinese families using third generation sequencing

Preservation of antigenic reactivity after cryofixation, cryosubstitution, and cryoembedding in Lowicryl HM23: Application to alcohol dehydrogenase in Drosophila fat body